AstraZeneca Plc. (AZN.L,AZN) announced Tuesday that the US Food and Drug Administration or FDA informed FibroGen, Inc. that it will convene a meeting of the Cardiovascular and Renal Drugs Advisory
Continue reading »Home ยป
FDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INO’s REVEAL 1 Meets Goals
Today’s Daily Dose brings you news about the regulatory set back of Athenex’s oral Paclitaxel and CorMedix’s Defencath, ASLAN Pharma’s Atopic Dermatitis trial results, FDA panel review of FibroGen’s Roxadustat,
Continue reading »NDAL MFG Recalls Manukaguard Allercleanse Nasal Spray
NDAL MFG Inc. called back one lot of Manukaguard Allercleanse nasal spray citing yeast contamination, the U.S. Food and Drug Administration said in a statement. The spray is used to
Continue reading »Nine Firms Issued Warning Letters Against Selling Unauthorized E-liquids
The U.S. Food and Drug Administration (FDA) has issued warning letters to nine firms who manufacture and operate websites selling electronic nicotine delivery system (ENDS) products, specifically e-liquids. The move
Continue reading »Novavax Does It Again!
Shares of Novavax Inc. (NVAX) set a fresh record high of $235.50 on Friday as investors cheered the company’s coronavirus vaccine trial results. The company’s protein-based COVID-19 vaccine candidate, NVX-CoV2373,
Continue reading »ACRS Soars On RA Trial Data, BHVN Disappoints In Alzheimer’s Trial, GRTS Joins COVID-19 Vaccine Race
Today’s Daily Dose brings you news about another Alzheimer’s disease drug failure, encouraging data of Aclaris’ rheumatoid arthritis trial; Royalty Pharma/Minerva deal; Gritstone joining the COVID-19 vaccine race; and FDA
Continue reading »FDA Panel Recommends Emergency Use Of Moderna’s COVID-19 Vaccine
The U.S. Food and Drug Administration’s vaccine advisory committee has recommended the emergency use of Moderna’s COVID-19 vaccine candidate mRNA-1273. If authorized, it would be the second COVID-19 vaccine available
Continue reading »CYCC Gets $7Mln Strategic Investment, SUPN Abuzz, SNGX Plunges On Oral Mucositis Trial Data
Today’s Daily Dose brings you news about BioCryst’s update on its investigational broad-spectrum antiviral Galidesivir in the treatment of COVID-19, a $7 million strategic investment by Acorn Bioventures in Cyclacel
Continue reading »The FDA has approved the first genetically modified pig for people with meat allergies
The FDA has approved a genetically modified pig for both human consumption and medicinal purposes. The pigs lack alpha-gal sugar, which causes an allergic reaction in those who have alpha-gal
Continue reading »BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech’s COVID-19 Vaccine Gets Green Light In UK
Today’s Daily Dose brings you news about the UK authorizing Pfizer/BioNTech’s COVID-19 mRNA vaccine BNT162b2 for emergency use, the anticipated event of BioCryst Pharma, Janssen acquiring rights to investigational gene
Continue reading »